Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced ...
EduBrisk Inclusive School Leaders’ Retreat for Tamil Nadu cohort marks push for inclusive classrooms
The three-day, invite-only programme brought together 20 CBSE school leaders from across Tamil Nadu. Participants at EduBrisk’s Inclusive School Leaders’ Retreat for the Tamil Nadu Cohort. EduBrisk ...
In 2022, Pfizer became the first biopharma company to generate annual revenue of $100 billion. | Led by cancer standout ...
Climber Alex Honnold is set to scale one of the world's tallest buildings without any ropes or safety nets.
The modern C-suite is moving past grit toward science-backed environmental wellness to end the day's chaos. Temi Ayodeji, ...
GlobalData on MSN
Vibrent Health to join BARDA-funded clinical trial
The new approach brings research directly to participants using decentralised and patient-centric digital engagement tools.
Many resolutions fail not because they are unrealistic, but because they are launched under conditions of high internal ...
Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
A Shiite-majority, Turkic-speaking state bordering Iran has become one of Israel’s closest strategic partners. That state is ...
At 33 years old and in his 13th year in the league, the Timberwolves' center is playing as well as he has ever played.
Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), Intel Corp. (INTC) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results